Get Mystery Box with random crypto!

UPDATES IN MEDICINE

Logo of telegram channel updates_in_medicine — UPDATES IN MEDICINE U
Logo of telegram channel updates_in_medicine — UPDATES IN MEDICINE
Channel address: @updates_in_medicine
Categories: Health
Language: English
Subscribers: 17.70K
Description from channel

Latest trending medical News, Research and Guidelines
Discussion Group
https://t.me/Professional_Medical_Discussion

Ratings & Reviews

2.67

3 reviews

Reviews can be left only by registered users. All reviews are moderated by admins.

5 stars

0

4 stars

1

3 stars

1

2 stars

0

1 stars

1


The latest Messages 8

2022-02-26 20:36:11 ​​​​ More Rapid Spread, Less Severe Disease with Omicron in South Africa

In Gauteng, where the omicron variant was first identified, two thirds of unvaccinated residents were seropositive for SARS-CoV-2, which indicates past infection. Omicron peaked just 1 month after being detected; hospitalizations and deaths did not increase in proportion to cases. Whether this change is related to widespread preexisting immunity or to features of the virus is unclear.

@Updates_in_Medicine
343 viewsedited  17:36
Open / Comment
2022-02-25 18:51:50
Which country do you support?
Anonymous Poll
22%
Russia
24%
Ukraine
54%
We don't need a war
1.9K voters571 views15:51
Open / Comment
2022-02-23 12:08:30 ​​ Gene Therapy for Sickle Cell Disease

An unprespecified interim analysis of results from a phase 1–2 study of gene therapy for sickle cell disease shows resolution of severe vaso-occlusive events in 25 patients who could be evaluated. In the 24 months before enrollment, these patients had a median of 3.5 severe vaso-occlusive events per year.


@Updates_in_Medicine
1.2K viewsedited  09:08
Open / Comment
2022-02-20 18:03:03 Get LIVE news coverage on the tense situation between Ukraine and Russia

Ukraine Russia Tensions LIVE

https://t.me/Ukraine_vs_Russia_Live
458 views15:03
Open / Comment
2022-02-18 10:16:16 ​​ A New Antiviral against Covid-19

Nirmatrelvir plus Ritonavir for Covid-19


Nirmatrelvir is an Mpro inhibitor active against SARS-CoV-2 and is given with ritonavir, a pharmacokinetic enhancer. In this double-blind, placebo-controlled trial, nirmatrelvir plus ritonavir, when given within 5 days after symptom onset to patients at high risk for disease progression, decreased the risk of Covid-19–related hospitalization or death by 87.8%.


@Updates_in_Medicine
156 viewsedited  07:16
Open / Comment
2022-02-16 05:03:37 ​​ Endovascular Therapy for Stroke with Large Infarctions

Endovascular therapy for stroke is generally avoided if the cerebral infarction is large. In a trial conducted in Japan, the percentage of patients who had a good functional outcome at 90 days was higher with endovascular therapy than with medical care, but there were more cerebral hemorrhages with endovascular therapy.


@Updates_in_Medicine
1.5K viewsedited  02:03
Open / Comment